Trius Therapeutics, Inc.
TSRX announced today that it has obtained a committed equity
financing facility under which it may from time to time sell up to $25 million
of its registered common stock to Terrapin Opportunity, L.P., over a 24-month
period. Trius is not obligated to utilize any of the $25 million facility and
remains free to enter into and consummate other equity and debt financing
transactions, subject to certain restrictions.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in